{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:37:50Z","timestamp":1792442270347,"version":"4.5.0"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002101, 82002096"],"award-info":[{"award-number":["82002101, 82002096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Skeletal muscle atrophy is a common complication in survivors of sepsis, which affects the respiratory and motor functions of patients, thus severely impacting their quality of life and long-term survival. Although several advances have been made in investigations on the pathogenetic mechanism of sepsis-induced skeletal muscle atrophy, the underlying mechanisms remain unclear. Findings from recent studies suggest that the nucleotide-binding and oligomerisation domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) inflammasome, a regulator of inflammation, may be crucial in the development of skeletal muscle atrophy. NLRP3 inhibitors contribute to the inhibition of catabolic processes, skeletal muscle atrophy and cachexia-induced inflammation. Here, we review the mechanisms by which NLRP3 mediates these responses and analyse how NLRP3 affects muscle wasting during inflammation.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1035709","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T05:23:25Z","timestamp":1667453005000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy"],"prefix":"10.3389","volume":"13","author":[{"given":"Yukun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s13054-020-03355-x","article-title":"Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness","volume":"24","author":"Mayer","year":"2020","journal-title":"Crit Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12964","article-title":"Risk factors for intensive care unit-acquired weakness: A systematic review and meta-analysis","volume":"138","author":"Yang","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2017.06.008","article-title":"Intensive care unit-acquired weakness","volume":"35","author":"Kramer","year":"2017","journal-title":"Neurol Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.06.006","article-title":"ICU-Acquired weakness: A rehabilitation perspective of diagnosis, treatment, and functional management","volume":"150","author":"Zorowitz","year":"2016","journal-title":"Chest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12153","article-title":"NLRP3 inflammasome in sepsis (Review)","volume":"24","author":"Shi","year":"2021","journal-title":"Mol Med Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10753-019-01124-9","article-title":"The NLRP3 inflammasome and its role in sepsis development","volume":"43","author":"Danielski","year":"2020","journal-title":"Inflammation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00650-z","article-title":"Inflammasomes as therapeutic targets in human diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduction Targeted Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10071020","article-title":"The role of melatonin on NLRP3 inflammasome activation in diseases","volume":"10","author":"Arioz","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10040524","article-title":"The impact of melatonin and NLRP3 inflammasome on the expression of microRNAs in aged muscle","volume":"10","author":"Sayed","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052523","article-title":"Inflammasome in ALS skeletal muscle: NLRP3 as a potential biomarker","volume":"22","author":"Moreno-Garcia","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev-nutr-071816-064836","article-title":"Fatty acids and NLRP3 inflammasome-mediated inflammation in metabolic tissues","volume":"37","author":"Ralston","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40635-016-0115-0","article-title":"Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy","volume":"5","author":"Huang","year":"2017","journal-title":"Intensive Care Med Exp"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113023","article-title":"Walking down skeletal muscle lane: From inflammasome to disease","volume":"10","author":"Dubuisson","year":"2021","journal-title":"Cells"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29268","article-title":"Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases","volume":"235","author":"Lu","year":"2020","journal-title":"J Cell Physiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25235533","article-title":"Inhibiting the NLRP3 inflammasome","volume":"25","author":"El-Sharkawy","year":"2020","journal-title":"Molecules"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: Mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nri2936","article-title":"Emerging inflammasome effector mechanisms","volume":"11","author":"Lamkanfi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-031210-101405","article-title":"The inflammasome NLRs in immunity, inflammation, and associated diseases","volume-title":"Annual Review Immuno","author":"Davis","year":"2011"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin d causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2016.02.019","article-title":"Pyroptosis","volume":"26","author":"Vande Walle","year":"2016","journal-title":"Curr Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408398.2022.2101425","article-title":"New insights into anti-diabetes effects and molecular mechanisms of dietary saponins","author":"Zhou","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-020-00388-1","article-title":"P2X7 receptor mediates NLRP3 inflammasome activation in depression and diabetes","volume":"10","author":"Wang","year":"2020","journal-title":"Cell Bioscience"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18020511","article-title":"Role of NLRP3 inflammasome activation in obesity-mediated metabolic disorders","volume":"18","author":"Wani","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2231","article-title":"Sensing and reacting to microbes through the inflammasomes","volume":"13","author":"Franchi","year":"2012","journal-title":"Nat Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: An overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020872","article-title":"Structure, activation and regulation of NLRP3 and AIM2 inflammasomes","volume":"22","author":"Sharma","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063254","article-title":"NLRP3 inflammasome: Potential role in obesity related low-grade inflammation and insulin resistance in skeletal muscle","volume":"22","author":"Jorquera","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/biom12071005","article-title":"Activation and pharmacological regulation of inflammasomes","volume":"12","author":"Chen","year":"2022","journal-title":"Biomolecules"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.571810","article-title":"Reactive oxygen species interact with NLRP3 inflammasomes and are involved in the inflammation of sepsis: From mechanism to treatment of progression","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Physiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00670-3","article-title":"An update on the regulatory mechanisms of NLRP3 inflammasome activation","volume":"18","author":"Paik","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1117765109","article-title":"Critical role for calcium mobilization in activation of the NLRP3 inflammasome","volume":"109","author":"Murakami","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.531202","article-title":"Lysosomes integrate metabolic-inflammatory cross-talk in primary macrophage inflammasome activation","volume":"289","author":"Weber","year":"2014","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402658","article-title":"K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling","volume":"194","author":"Katsnelson","year":"2015","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.6.3029","article-title":"Ca2+ stores and Ca2+ entry differentially contribute to the release of IL-1 beta and IL-1 alpha from murine macrophages","volume":"170","author":"Brough","year":"2003","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/10715762.2019.1630735","article-title":"Mitochondrial ROS and NLRP3 inflammasome in acute ozone-induced murine model of airway inflammation and bronchial hyperresponsiveness","volume":"53","author":"Xu","year":"2019","journal-title":"Free Radic Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.661811","article-title":"Enhanced IL-1beta release following NLRP3 and AIM2 inflammasome stimulation is linked to mtROS in airway macrophages in pulmonary fibrosis","volume":"12","author":"Trachalaki","year":"2021","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41419-021-03813-6","article-title":"CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys","volume":"12","author":"Hou","year":"2021","journal-title":"Cell Death Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/bab.1700","article-title":"Role and mechanism of ROS scavengers in alleviating NLRP3-mediated inflammation","volume":"66","author":"Sho","year":"2019","journal-title":"Biotechnol Appl Biochem"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasome activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5582\/bst.2020.01029","article-title":"NEK7: a potential therapy target for NLRP3-related diseases","volume":"14","author":"Liu","year":"2020","journal-title":"Biosci Trends"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2018.09.010","article-title":"The role of mitochondria in NLRP3 inflammasome activation","volume":"103","author":"Liu","year":"2018","journal-title":"Mol Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00167","article-title":"Cathepsin b is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction","volume":"8","author":"Chevriaux","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jes.2021.04.021","article-title":"NLRP3 inflammasome activation determines the fibrogenic potential of PM2.5 air pollution particles in the lung","volume":"111","author":"Cao","year":"2022","journal-title":"J Environ Sci (China)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1126\/science.1217141","article-title":"GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals","volume":"336","author":"Shenoy","year":"2012","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yexcr.2017.03.028","article-title":"PKR induces the expression of NLRP3 by regulating the NF-\u03baB pathway in porphyromonas gingivalis-infected osteoblasts","volume":"354","author":"Yoshida","year":"2017","journal-title":"Exp Cell Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04581-2","article-title":"Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation","volume":"9","author":"Lang","year":"2018","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15986","article-title":"MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25123-2","article-title":"Hsp90 inhibition as a means to inhibit activation of the NLRP3 inflammasome","volume":"8","author":"Piippo","year":"2018","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/ni1459","article-title":"A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses","volume":"8","author":"Mayor","year":"2007","journal-title":"Nat Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.07.018","article-title":"The PYRIN domain-only protein POP1 inhibits inflammasome assembly and ameliorates inflammatory disease","volume":"43","author":"de Almeida","year":"2015","journal-title":"Immunity"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15556","article-title":"The PYRIN domain-only protein POP2 inhibits inflammasome priming and activation","volume":"8","author":"Ratsimandresy","year":"2017","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12867","article-title":"Sepsis induces interleukin 6, gp130\/JAK2\/STAT3, and muscle wasting","volume":"13","author":"Zanders","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B64","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1016\/j.nmd.2017.06.029","article-title":"EC.O.7 - necroptosis, a programmed form of necrosis, participates in muscle degeneration in duchenne muscular dystrophy","volume":"27","author":"Bencze","year":"2017","journal-title":"Neuromuscular Disord"},{"key":"B65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1242\/dmm.010389","article-title":"Cellular and molecular mechanisms of muscle atrophy","volume":"6","author":"Bonaldo","year":"2013","journal-title":"Dis Model Mech"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-019-0355-1","article-title":"Mitochondrial dysfunction\/NLRP3 inflammasome axis contributes to angiotensin II-induced skeletal muscle wasting via PPAR-gamma","volume":"100","author":"Liu","year":"2020","journal-title":"Lab Invest"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12763","article-title":"Inhibition of the NLRP3\/IL-1beta axis protects against sepsis-induced cardiomyopathy","volume":"12","author":"Busch","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13941","article-title":"Imoxin attenuates LPS-induced inflammation and MuRF1 expression in mouse skeletal muscle","volume":"6","author":"Valentine","year":"2018","journal-title":"Physiol Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bbrc.2017.02.021","article-title":"Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression","volume":"485","author":"Li","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1111\/bph.15472","article-title":"Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-kappaB\/TNF-alpha and regulating protein synthesis\/degradation pathway","volume":"178","author":"Fang","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a ss-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqy170","article-title":"Effects of 3-hydroxybutyrate and free fatty acids on muscle protein kinetics and signaling during LPS-induced inflammation in humans: Anticatabolic impact of ketone bodies","volume":"108","author":"Thomsen","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1177\/1535370220931038","article-title":"Protective effect of exogenous hydrogen sulfide on diaphragm muscle fibrosis in streptozotocin-induced diabetic rats","volume":"245","author":"Yang","year":"2020","journal-title":"Exp Biol Med (Maywood)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.113.000381","article-title":"Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice","volume":"7","author":"Toldo","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00683-y","article-title":"RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor","volume":"18","author":"Chen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102975118","article-title":"Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration","volume":"118","author":"Ambati","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107358","article-title":"NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages","volume":"92","author":"Shi","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat Commun"},{"key":"B80","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nature11290","article-title":"Novel role of PKR in inflammasome activation and HMGB1 release","volume":"488","author":"Lu","year":"2012","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.01.009","article-title":"An acetylation switch of the NLRP3 inflammasome regulates aging-associated chronic inflammation and insulin resistance","volume":"31","author":"He","year":"2020","journal-title":"Cell Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108756","article-title":"Itaconate confers tolerance to late NLRP3 inflammasome activation","volume":"34","author":"Bambouskova","year":"2021","journal-title":"Cell Rep"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.07.016","article-title":"The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation","volume":"32","author":"Hooftman","year":"2020","journal-title":"Cell Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1126\/science.1240248","article-title":"Noncanonical inflammasome activation by intracellular LPS independent of TLR4","volume":"341","author":"Kayagaki","year":"2013","journal-title":"Science"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP- hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat Chem Biol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-019-0278-6","article-title":"MCC950 closes the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abelian","year":"2019","journal-title":"Nat Chem Biol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discovery"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910212","article-title":"Activation of the NLRP3 inflammasome increases the IL-1beta level and decreases GLUT4 translocation in skeletal muscle during insulin resistance","volume":"22","author":"Americo-Da-Silva","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10753-016-0449-5","article-title":"Activation of the NLRP3 inflammasome is associated with valosin-containing protein myopathy","volume":"40","author":"Nalbandian","year":"2017","journal-title":"Inflammation"},{"key":"B91","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.nmd.2021.07.113","article-title":"DMD\u2013ANIMAL MODELS: EP. 88 inflammasome inhibitors for the treatment of muscular dystrophies","volume":"31","author":"Dubuisson","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01924","article-title":"Development of novel tetrahydroquinoline inhibitors of NLRP3 inflammasome for potential treatment of DSS-induced mouse colitis","volume":"64","author":"Dai","year":"2021","journal-title":"J Medicinal Chem"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J Exp Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.515080","article-title":"3,4-methylenedioxy-beta-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome","volume":"289","author":"He","year":"2014","journal-title":"J Biol Chem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15314-8","article-title":"BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination","volume":"7","author":"Shim","year":"2017","journal-title":"Sci Rep"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04947-6","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1947","article-title":"Expression of P2X7 receptor increases In vivo tumor growth","volume":"72","author":"Adinolfi","year":"2012","journal-title":"Cancer Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12774","article-title":"P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"30","author":"Fabbrizio","year":"2020","journal-title":"Brain Pathol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2017.12.021","article-title":"The P2X7 receptor: A main player in inflammation","volume":"151","author":"Adinolfi","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7956274","article-title":"Inhibition of P2X7 purinergic receptor ameliorates cardiac fibrosis by suppressing NLRP3\/IL-1 \u03b2 pathway","volume":"2020","author":"Zhou","year":"2020","journal-title":"Oxid Med Cell Longevity"},{"key":"B101","doi-asserted-by":"publisher","first-page":"107810","DOI":"10.1016\/j.intimp.2021.107810","article-title":"Study of the correlation between the noncanonical pathway of pyroptosis and idiopathic inflammatory myopathy","volume":"98","author":"Ma","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04420-1","article-title":"Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases","volume":"12","author":"Soriano-Teruel","year":"2021","journal-title":"Cell Death Dis"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01826-0","article-title":"IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis","volume":"17","author":"Desu","year":"2020","journal-title":"J Neuroinflamm"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108868","article-title":"Carbenoxolone ameliorates insulin sensitivity in obese mice induced by high fat diet via regulating the I kappa b-alpha\/NF-kappa b pathway and NLRP3 inflammasome","volume":"115","author":"Chen","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gly059","article-title":"The protective effect of melatonin against age-associated, sarcopenia-dependent tubular aggregate formation, lactate depletion, and mitochondrial changes","volume":"73","author":"Sayed","year":"2018","journal-title":"Journals Gerontol - Ser A Biol Sci Med Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-018-0466-0","article-title":"Curcumin ameliorates palmitate-induced inflammation in skeletal muscle cells by regulating JNK\/NF-kB pathway and ROS production","volume":"26","author":"Sadeghi","year":"2018","journal-title":"Inflammopharmacology"},{"key":"B107","doi-asserted-by":"crossref","DOI":"10.1016\/S1016-8478(23)17614-X","article-title":"Curcumin alleviates dystrophic muscle pathology in mdx mice","volume":"25","author":"Pan","year":"2008","journal-title":"Molecules Cells"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-015-0051-9","article-title":"Involvement of adiponectin in the pathogenesis of dystrophinopathy","volume":"5","author":"Abou-Samra","year":"2015","journal-title":"Skeletal Muscle"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.642908","article-title":"Metformin increases sarcolemma integrity and ameliorates neuromuscular deficits in a murine model of duchenne muscular dystrophy","volume":"12","author":"Dong","year":"2021","journal-title":"Front Physiol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00357.2013","article-title":"Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1\u03b1 axis","volume":"307","author":"Ljubicic","year":"2014","journal-title":"Am J Physiol - Cell Physiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12915-018-0501-z","article-title":"Downregulation of the NLRP3 inflammasome by adiponectin rescues duchenne muscular dystrophy","volume":"16","author":"Boursereau","year":"2018","journal-title":"BMC Biol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116654","article-title":"Ghrelin improves muscle function in dystrophin-deficient mdx mice by inhibiting NLRP3 inflammasome activation","volume":"232","author":"Chang","year":"2019","journal-title":"Life Sci"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.02.043","article-title":"Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition","volume":"658","author":"Lu","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159826","article-title":"Shikonin suppresses NLRP3 and AIM2 inflammasomes by direct inhibition of caspase-1","volume":"11","author":"Zorman","year":"2016","journal-title":"PLoS One"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2015.07.014","article-title":"Lipidomic evidence that lowering the typical dietary palmitate to oleate ratio in humans decreases the leukocyte production of proinflammatory cytokines and muscle expression of redox-sensitive genes","volume":"26","author":"Kien","year":"2015","journal-title":"J Nutr Biochem"},{"key":"B116","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41420-021-00648-0","article-title":"Trimetazidine attenuates dexamethasone-induced muscle atrophy via inhibiting NLRP3\/GSDMD pathway-mediated pyroptosis","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discovery"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.818326","article-title":"Piperlongumine is an NLRP3 inhibitor with anti-inflammatory activity","volume":"12","author":"Shi","year":"2022","journal-title":"Front Pharmacol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202153499","article-title":"Licochalcone b specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction","volume":"23","author":"Li","year":"2022","journal-title":"EMBO Rep"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.09.017","article-title":"Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease","volume":"91","author":"Ahmed","year":"2021","journal-title":"Brain Behav Immun"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101548","article-title":"Andrographolide suppresses osteoarthritis progression by regulating circ_Rapgef1\/miR-383-3p\/NLRP3 signaling axis","volume":"71","author":"Yan","year":"2022","journal-title":"Transplant Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2021.03.025","article-title":"Brevilin a inhibits NLRP3 inflammasome activation in vivo and in vitro by acting on the upstream of NLRP3-induced ASC oligomerization","volume":"135","author":"Qin","year":"2021","journal-title":"Mol Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-00527-x","article-title":"Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation","volume":"42","author":"Zhao","year":"2021","journal-title":"Acta Pharmacologica Sin"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01007","article-title":"Discovery of novel pterostilbene-based derivatives as potent and orally active NLRP3 inflammasome inhibitors with inflammatory activity for colitis","volume":"64","author":"Chen","year":"2021","journal-title":"J Medicinal Chem"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01743","article-title":"Berberine directly targets the NEK7 protein to block the NEK7-NLRP3 interaction and exert anti-inflammatory activity","volume":"64","author":"Zeng","year":"2021","journal-title":"J Medicinal Chem"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.111344","article-title":"(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme\/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1 beta and IL-18","volume":"321","author":"Wannamaker","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2008.08.024","article-title":"Ritonavir and disulfiram have potential to inhibit caspase-1 mediated inflammation and reduce neurological sequelae after minor blast exposure","volume":"72","author":"Foley","year":"2009","journal-title":"Med Hypotheses"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat Rev Drug Discovery"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0669-6","article-title":"FDA-Approved disulfiram inhibits pyroptosis by blocking gasdermin d pore formation","volume":"21","author":"Hu","year":"2020","journal-title":"Nat Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.07.768","article-title":"Arterial effects of canakinumab in patients with atherosclerosis and type 2 diabetes or glucose intolerance","volume":"68","author":"Choudhury","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X19859072","article-title":"A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease","volume":"24","author":"Russell","year":"2019","journal-title":"Vasc Med (United Kingdom)"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb9818","article-title":"Succination inactivates gasdermin d and blocks pyroptosis","volume":"369","author":"Humphries","year":"2020","journal-title":"Science"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1035709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T04:10:22Z","timestamp":1728274222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1035709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":131,"alternative-id":["10.3389\/fimmu.2022.1035709"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1035709","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]},"article-number":"1035709"}}